SERAC1 (SRAC1_HUMAN) as a Drug Target and Biomarker (G84947)

Target Name: SERAC1

NCBI ID: G84947

SERAC1

SERAC1 (SRAC1_HUMAN) as a Drug Target and Biomarker

Abstract:

Serac1 (SRAC1_HUMAN) is a protein that is expressed in various tissues of the human body. It is involved in the regulation of cell growth, differentiation, and survival. The study of Serac1 has gained significant interest in recent years, and its potential as a drug target and biomarker has been proposed. This article will summarize the current research on Serac1, including its expression and function, its potential as a drug target, and its potential as a biomarker for various diseases.

Introduction:

Serac1 (SRAC1_HUMAN) is a non-coding RNA molecule that is expressed in various tissues of the human body. It is involved in the regulation of cell growth, differentiation, and survival. The study of Serac1 has gained significant interest in recent years, and its potential as a drug target and biomarker has been proposed.

Serac1 Expression and Function:

Serac1 is a non-coding RNA molecule that is expressed in various tissues of the human body. It is composed of 198 non-coding RNA modules and has a molecular weight of approximately 2.9 kDa. Serac1 is predominantly expressed in the brain, heart, liver, and muscle tissues of the human body. It is also expressed in various other tissues, including the placenta, axillary tissue, and skin.

Serac1 plays a critical role in the regulation of cell growth, differentiation, and survival. It is involved in the regulation of cell proliferation, cell survival, and the regulation of cell-cell interactions. It is also involved in the regulation of cell-to -cell adhesion and in the regulation of cell migration.

Serac1 has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that Serac1 is involved in the regulation of the growth and survival of cancer cells, and that it is a potential drug target for cancer treatment.

Serac1 as a Drug Target:

Serac1 has been shown to be involved in the regulation of a wide range of cellular processes, making it an attractive drug target. Its involvement in cell growth, differentiation, and survival makes it a potential target for a variety of drugs, including anti-cancer drugs, anti-inflammatory drugs, and neurodegenerative drugs.

One of the main advantages of Serac1 as a drug target is its promiscuity. Because it is involved in a variety of biological processes, it can be targeted with a variety of drugs. Additionally, its role in cell survival and growth makes it a potential target for drugs that are designed to inhibit cell proliferation or survival.

Serac1 has also been shown to interact with a wide range of molecules, including transcription factors, proteins involved in cell adhesion, and signaling pathways. This makes it a potential target for drugs that can modulate these interactions.

Serac1 as a Biomarker:

Serac1 has also been shown to be involved in the regulation of various biological processes, making it an attractive biomarker for a variety of diseases. Its involvement in cell growth, differentiation, and survival makes it a potential biomarker for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

For example, studies have shown that Serac1 is involved in the regulation of the growth and survival of cancer cells, and that it is a potential biomarker for cancer. Additionally, its involvement in the regulation of neurodegenerative diseases makes it a potential biomarker for conditions such as Alzheimer's disease and Parkinson's disease.

Conclusion:

Serac1 (SRAC1_HUMAN) is a non-coding RNA molecule that is expressed in various tissues of the human body. It is involved in the regulation of cell growth, differentiation, and survival, and has been shown to play a role in the development and progression of various diseases. Its potential as a drug target and biomarker has

Protein Name: Serine Active Site Containing 1

Functions: Plays an important role in the phosphatidylglycerol remodeling that is essential for both mitochondrial function and intracellular cholesterol trafficking. May catalyze the remodeling of phosphatidylglycerol and be involved in the transacylation-acylation reaction to produce phosphatidylglycerol-36:1. May be involved in bis(monoacylglycerol)phosphate biosynthetic pathway

The "SERAC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SERAC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets